AstraZeneca’s $2.4B deal for cancer-fighting drug
AstraZeneca, the British/Swedish global pharmaceutical firm with a longtime US base in Wilmington, acquired California-based Fusion Pharmaceuticals for $2.4 billion, adding a potential prostate cancer treatment drug to its portfolio.
Also, Solenis is on a roll, announcing the acquisition of two sustainable cleaning product chemical companies a few days apart, and we’ve got a new data viz showing which companies are hiring the most tech workers in the region this month.
➡️ Get all the details in the latest edition of Money Moves
Delaware tech folks convene in Wilmington
The second annual Tech Ecosystem Conference takes over the Riverfront Events center in Wilmington next week with two days of programming. The program on June 25 includes a Black Men Talk Tech panel discussion, a breakfast symposium and more, and the June 26 lineup continues with a panel on AI in the workforce, and a look at the future of the Tech Council of Delaware.
Step away from the daily grind to engage with industry leaders, hear from exciting speakers and meet innovative startup entrepreneurs, all while enjoying good food and fun swag.
➡️ Get your ticket now — admission starts at $65
[This sponsored note helps support our journalism. Interested? Let us know.]
News Incubator: What else to know today
• Need to cool off? Here’s a roundup of Wilmington’s public spray parks and other places to find relief from the heat. [WDEL]
• Business is bustling in Milford, where the population has doubled over the last 30 years. [Delaware Business Times]
• Newark-based GOLO, a wellness and weight loss company, just won a BBB award. [Delaware Business Now]
• The Wilmington Learning Collaborative has a new look, complete with website and logo, by First Ascent Design. [Town Square Delaware]
🗓️ On the Calendar
Welcome to the daily roundup of the latest from Delaware's tech and entrepreneurship scene. Want this in your inbox? Subscribe for free.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
